Showing results (111-120 of 190) with videos related to
Sort By:
Pageof 19
Carcinogenesis|December 8, 2005
Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cellsFiona McPhillips, Peter Mullen, Kenneth G MacLeod, et al.European Urology|March 27, 2018
Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder CancerMichal Sarfaty, Peter S Hall, Kelvin K W Chan, et al.European Journal of Cancer (Oxford, England : 1990)|August 10, 2018
Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane ProjectAlastair M Thompson, Karen Clements, Shan Cheung, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative GroupRobert J Paridaens, Luc Y Dirix, Louk V Beex, et al.British Journal of Cancer|July 12, 2018
Harnessing citizen science through mobile phone technology to screen for immunohistochemical biomarkers in bladder cancerPeter Smittenaar, Alexandra K Walker, Shaun McGill, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancerJ Michael Dixon, Lorna Renshaw, Oliver Young, et al.Exploration of Targeted Anti-Tumor Therapy|April 20, 2022
Collateral-resistance to estrogen and HER-activated growth is associated with modified AKT, ERα, and cell-cycle signaling in a breast cancer modelKate M Moore, Vera Cerqueira, Kenneth G MacLeod, et al.BMC Cancer|April 7, 2018
Adjuvant trastuzumab duration trials in HER2 positive breast cancer - what results would be practice-changing? Persephone investigator questionnaire prior to primary endpoint resultsLouise Hiller, Janet A Dunn, Shrushma Loi, et al.Breast (Edinburgh, Scotland)|June 4, 2026
EBCC-15 manifesto: Removing age-related barriers to improve equity in breast cancer careFiorita Poulakaki, Etienne Brain, Icro Meattini, et al.Breast Cancer Research and Treatment|June 4, 2011
In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancerMelanie Spears, Karen J Taylor, Alison F Munro, et al.Pageof 19